Scapular Dyskinesis With Impingement Syndrome

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorChuncheon Sacred Heart Hospital

About this trial

The goal of this study is to diagnose scapular dyskinesis-which can appear as a cause or result of various shoulder disorders-through screening tests in patients with shoulder impingement syndrome, the most common shoulder condition. By identifying scapular dyskinesis, the study aims to maximize treatment outcomes through appropriate rehabilitative exercise therapy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients diagnosed with unilateral shoulder impingement syndrome in the outpatient clinic (based on clinical symptoms and MRI) from the IRB approval date until March 1, 2027

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • SD rehabilitation

    Behavioral

    For shoulder impingement syndrome, the standard rehabilitation protocol involves administering a subacromial steroid injection at the initial outpatient visit, followed by stick exercises to restore joint mobility starting three weeks later. Four weeks after initiating the stick exercises, rotator cuff strengthening exercises using therabands are introduced and maintained for a duration of six weeks. For SD rehabilitation, shoulder external rotation, push up plus, and shoulder rolls were performed. In the experimental group, rehabilitation for scapular dyskinesis will begin at the second outpatient visit, which takes place three weeks after the subacromial steroid injection.

  • No SD rehabilitation

    Behavioral

    For shoulder impingement syndrome, the standard rehabilitation protocol involves administering a subacromial steroid injection at the initial outpatient visit, followed by stick exercises to restore joint mobility starting three weeks later. Four weeks after initiating the stick exercises, rotator cuff strengthening exercises using therabands are introduced and maintained for a duration of six weeks. In the sham group, rehabilitation for scapular dyskinesis will not begun at the second outpatient visit, which takes place three weeks after the subacromial steroid injection.

Treatment groups

360 Participants
are divided into 2 treatment groups
Group A: Impinge c SD treatmentExperimental treatment 1 intervention
Group B: Impinge s SD treatmentSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

visual analog pain scale (VAS)

0-10, 0: not satisfied, 10: very much satisfied

Time frame
Initial, 3, 7, 13 weeks

Secondary outcomes

1

American Shoulder and Elbow Surgeons' (ASES) score

0-100

Time frame
Initial, 3, 7,13 weeks
2

Constant score

0-100

Time frame
Initial, 3, 7, 13 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: